RPT-Advaxis, Merck to test immune therapies against prostate cancer
August 25, 2014 at 07:00 AM EDT
Aug 25 (Reuters) - Advaxis Inc on Monday said it will test an experimental immuno-oncology drug in combination with a high-profile immunotherapy from Merck & Co Inc as a treatment for patients with advanced prostate cancer.
